Roles and Responsibilities

Principal Investigator, Biosciences Institute, https://www.ncl.ac.uk/medical-sciences/research/institutes/biosciences/ 

Newcastle University Cancer Centre

Qualifications

1971 Imperial College BSc (Hons) Physics.
1971 ARCS (Associate of the Royal College of Science)
1978 PhD Biophysics (Cellular and Molecular Biology)
Queen Elizabeth/Kings College, University of London.
1986 CRC/University of Glasgow, Recombinant DNA Training Fellowship.

2012 MRCR Hon Membership Royal College of Radiologists

2013 FRCPath Fellowship Royal College of Pathologists

Previous Positions

1999-2003
Gillespie Reader in Molecular Oncology and Assistant Director,
Cancer Research Unit, University of Newcastle upon Tyne
1994-1999
Senior Lecturer,
Cancer Research Unit, University of Newcastle
1990-1994
Lecturer,
Cancer Research Unit, University of Newcastle
1986-1990
Postdoctoral Research Associate,
Cancer Research Unit, University of Newcastle
1983-1986
Recombinant DNA Fellowship,
Institute of Genetics, University of Glasgow
1975-1983
MRC Scientist
MRC Cyclotron Unit, Royal Postgrad Medical School, Hammersmith Hosp.

Memberships

British Association for Cancer Research
American Association for Cancer Research (Emeritus) 
European Neuroblastoma Study Group
United Kingdom Children's Cancer Neuroblastoma Study Group

Royal College of Radiologists (Hon)

Royal College of Pathologists (Fellowship)

Local Research Groups:-
Newcastle University Cancer Centre
Gynaecologicol Oncology Research Group
Children's Cancer Research Group

Research Interests

Molecular Biology of Cancer

Esteem Indicators

Gillespie Readership and Chair in Molecular Oncology
Royal College of Radiologists Cancer Biology Specialist Examiner
American Institute of Biological Sciences Expert Consultant Panel
Leukaemia Research Fund Medical and Scientific Advisory Panel

MRC Developmental Pathway Funding Panel (2011-2014) 

MRC Doctoral Training Panel (2015 - )

EPSRC Peer Review College (2016 - )

Editorial boards:
Oncology Reports -1998
European Journal of Cancer 2003 –
Current Cancer Therapy Reviews 2004 -

Industrial Collaborations:

Lilly Pharmaceuticals
Astra Zeneca
Siena Biotech
Novocastra (BioNet studentship)
Cancer Research Technology

Patents

Isoindolinone inhibitors of the MDM2-p53 interaction.
(In conjunction with Cancer Research Technology)

Undergraduate Teaching

BSc Pharmacology PED3006 Module Leader: "Carcinogenesis and Anticancer Drugs"

Postgraduate Teaching

MSc in Oncology/Palliative Care,
Module Leader for ONC8022 "Cancer Cell, Molecular Biology & Genetics".
Postgraduate Tutor
PhD and MD supervisor:
Successfully supervised 49 PhD, 6 MD & 8 MSc/MPhil students
Currently supervise 6 PhD students